IntegraGen SA Becomes First Certified French Service Provider for Illumina, Inc. GoldenGate and Infinium Genotyping

SAN DIEGO--(BUSINESS WIRE)--Concurrent with the annual European Human Genetics Conference in Nice, France, Illumina, Inc. (NASDAQ:ILMN) announced today that IntegraGen SA, a personalized healthcare company focused on the development and commercialization of molecular diagnostic tests for complex diseases and provider of genetic services, has received Illumina Certified Service Provider (CSPro™) certification for GoldenGate® and Infinium® genotyping technologies.